Diabetes CPE Series: March activity available now

Welcome to the seventh and last knowledge-based activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The March activity covers drug-induced hyperglycemia and hypoglycemia, nonprescription medications, and complementary and alternative medicine for diabetes care.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

New online interactive case studies available now

Welcome to Case Studies in Diabetes Care-Part 1. This is the first of three studies offering you an opportunity to apply diabetes management concepts from the knowledge-based diabetes series. Earn 1 hour of CPE credit by completing this application-based activity.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

2012 specialty Rx drug spending hits all-time high

The Express Scripts 2012 Drug Trend Report shows specialty prescription drugs accounted for almost one-quarter of the U.S. total drug costs last year—an all-time high. Read on for more interesting facts and figures. » More

CPPA creates accreditation standards for pharmacies

The Center for Pharmacy Practice Accreditation has created specific standards for pharmacies to meet to achieve accreditation, a distinction that will help improve patient outcomes and formally recognize pharmacies that are committed to high-quality, innovative, and safe practices. » More

Extended dabigatran use reduces recurrent VTE risk

Dabigatran used beyond the initial 3 months of treatment at a dose of 150 mg twice daily reduced the risk of recurrent venous thromboembolism, according to a study recently published in the New England Journal of Medicine. » More

TAKE OUR SURVEY

The "60 Minutes" story on the NECC meningitis outbreak takes a deeper, more personal look into the tragedy.